EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies

Roula Khalil iD, Mona Diab-Assaf, Jean-Marc Lemaitre iD

Cells · 2023

DOI: 10.3390/cells12060915 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Roula Khalil und 2 weiteren Autor:innen. Beteiligte Einrichtung: IRMB, University Montpellier, INSERM, 34090 Montpellier, France. Hauptthemen laut MEDLINE: Cellular Senescence, Aging, Chronic Disease. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Life expectancy has drastically increased over the last few decades worldwide, with important social and medical burdens and costs. To stay healthy longer and to avoid chronic disease have become essential issues. Organismal aging is a complex process that involves progressive destruction of tissue functionality and loss of regenerative capacity. One of the most important aging hallmarks is cellular senescence, which is a stable state of cell cycle arrest that occurs in response to cumulated cell stresses and damages. Cellular senescence is a physiological mechanism that has both beneficial and detrimental consequences. Senescence limits tumorigenesis, lifelong tissue damage, and is involved in different biological processes, such as morphogenesis, regeneration, and wound healing. However, in the elderly, senescent cells increasingly accumulate in several organs and secrete a combination of senescence associated factors, contributing to the development of various age-related diseases, including cancer. Several studies have revealed major molecular pathways controlling the senescent phenotype, as well as the ones regulating its interactions with the immune system. Attenuating the senescence-associated secretory phenotype (SASP) or eliminating senescent cells have emerged as attractive strategies aiming to reverse or delay the onset of aging diseases. Here, we review current senotherapies designed to suppress the deleterious effect of SASP by senomorphics or to selectively kill senescent cells by “senolytics” or by immune system-based approaches. These recent investigations are promising as radical new controls of aging pathologies and associated multimorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceAgingChronic DiseaseHumansAnimalsApoptosisSenotherapeuticsAntibody-Dependent Cell Cytotoxicity

Stichwörter der Autor:innen

SASPage-related disorderscellular senescenceimmune surveillancesenolytic drugs

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • IRMB, University Montpellier, INSERM, 34090 Montpellier, France.
  • Fanar Faculty of Sciences II, Lebanese University, Beirut P.O. Box 90656, Lebanon.

ORCID-Profile: Roula Khalil, Jean-Marc Lemaitre

Zitieren

APA

Khalil, R., Diab-Assaf, M., & Lemaitre, J. M. (2023). Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. Cells. https://doi.org/10.3390/cells12060915

Vancouver

Khalil R, Diab-Assaf M, Lemaitre JM. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. Cells. 2023. doi:10.3390/cells12060915

BibTeX
@article{Khalil2023,
  author = {Khalil, Roula and Diab-Assaf, Mona and Lemaitre, Jean-Marc},
  title = {Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12060915}
}
Kostenlos starten →